Source: BIO NANO INSIDER Newsletter - Published by the Italian Trade Commission of Los Angeles
Contact: losangeles@losangeles.ice.it

Rome-based NewCorTec SpA announced earlier this year the first implantation of its BestBeat® Ventricular Assist Device (VAD). The artificial heart developed at Italy’s National Research Center (CNR) and manufactured by NewCorTec was used to treat a 68 year-old German patient at the Cardiosurgical Center of University of Bochum. Research on the device is also underway at centers in France and Italy. According to Professor Luigi Donato – who serves as director of the CNR’s Institute of Clinical Physiology and is considered the “father” of NewCorTec’s technology – the company hopes obtain European Certification (EC Mark) for the BestBeat device by Spring 2008.

More information is available at www.newcortec.com.